Le Lézard
Classified in: Health
Subject: RCL

NDAL MFG INC Issues Voluntary Nationwide Recall of ManukaGuard Allercleanse Nasal Spray Due to Contamination with Yeast


MONTEREY, Calif., Feb. 11, 2021 /PRNewswire/ -- NDAL MFG INC is voluntarily recalling one lot of Manukaguard Allercleanse, nasal spray to the consumer level. The Allercleanse nasal sprays have been found to be contaminated with yeast.

Voluntary Recall of Allercleanse 40mL Lot 2010045

Risk Statement: The use of Allercleanse (manuka honey) nasal spray contaminated with yeasts, in the population most likely to use it (children, adults, and elderly), may result in adverse events that necessitate medical or surgical intervention. However, use of this contaminated product in immunosuppressed individuals may result in life threatening invasive fungal infections. NDAL MFG INC has not received any reports of adverse events related to this recall.

The product is used as a NASAL SPRAY to clean nasal passages and sinuses of irritants and other environmental contaminants and is packaged in cardboard box with one nasal spray per box UPC 858631002128.  The affected Allercleanse lot is lot # 2010045 and BB 10/2023 expiration date. Product was distributed Nationwide in the USA to 1 e-commerce website amazon.com, distributors and retail stores.

NDAL MFG INC has notified its distributors and customers by e-mail followed by telephone and further email and has arranged for return/replacement etc. of all recalled products.  Consumers/distributors/retailers that have product which is being recalled should stop using/return to place of purchase/discard/contact their doctor, etc., if they have not already done so.

Consumers with questions regarding this recall can contact NDAL MFG INC by phone 1-800-916-1220 or e-mail address [email protected], M-F 7:30 am to 4 pm PST.  Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

 

SOURCE NDAL MFG INC


These press releases may also interest you

at 23:00
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

at 23:00
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:33
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....



News published on and distributed by: